Capitolis Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-58,171
Closed -$14.9M 295
2021
Q4
$14.9M Buy
58,171
+30,000
+106% +$7.34M 0.09% 169
2021
Q3
$6.95M Hold
28,171
0.06% 210
2021
Q2
$5.82M Sell
28,171
-79,516
-74% -$16.2M 0.07% 208
2021
Q1
$20.3M Hold
107,687
0.35% 70
2020
Q4
$17.7M Buy
+107,687
New +$15.7M 0.3% 83

Other funds holding HCA

Capitolis Advisors's HCA Position: Q1 2022 in Review

Capitolis Advisors sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 58,171 shares — an estimated $14.9M sold.

Capitolis Advisors first reported a position in HCA in Q4 2020 and held it in 5 quarters. The position peaked at $20.3M in Q1 2021. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

  • Capitolis Advisors reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 58,171 HCA Healthcare shares in Q1 2022, an estimated $14.9M.
  • Capitolis Advisors first reported a position in HCA Healthcare in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's HCA Healthcare position peaked at $20.3M in Q1 2021.
  • 968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.